Background A severe form of encephalitis associated with antibodies against NR1–NR2
heteromers of the NMDA receptor was recently identified. We aimed to analyse the clinical and …

Background Anti-NMDA receptor (NMDAR) encephalitis is an autoimmune disorder in which
the use of immunotherapy and the long-term outcome have not been defined. We aimed to …

Since its discovery in 2007, the encephalitis associated with antibodies against the N-methyl-D-aspartate
receptor (NMDAR) has entered the mainstream of neurology and other …

We recently described a severe, potentially lethal, but treatment-responsive encephalitis that
associates with autoantibodies to the NMDA receptor (NMDAR) and results in behavioral …

Objective To report the clinical and immunological features of a novel autoantigen related to
limbic encephalitis (LE) and the effect of patients' antibodies on neuronal cultures. Methods …

Background Some encephalitides or seizure disorders once thought idiopathic now seem to
be immune mediated. We aimed to describe the clinical features of one such disorder and …

Background Anti-N-methyl-d-aspartate (NMDA) receptor encephalitis is a severe but treatable
autoimmune disorder which diagnosis depends on sensitive and specific antibody testing. …

Background Voltage-gated potassium channels are thought to be the target of antibodies
associated with limbic encephalitis. However, antibody testing using cells expressing voltage-…

Background Increasing evidence suggests that seizures and status epilepticus can be
immune-mediated. We aimed to describe the clinical features of a new epileptic disorder, and to …

Anti-N-methyl D-aspartate receptor (NMDAR) encephalitis is a severe neuropsychiatric
disorder that associates with prominent memory and behavioural deficits. Patients’ antibodies …